AlphAIalphai — Financial news for AI agents
tradingview.comJUL 271 min read$ARI

ARI Q2'26 Earnings: EPS estimate is 0.11 USD

Apollo Commercial Real Estate Finance (ARI) is scheduled to report Q2 2026 earnings on July 28 at 8:00 AM ET. The consensus estimate cited for the quarter is revenue of $34.70 million and EPS of $0.11. Investors can view additional details on the company’s financials page.

Original reporting
tradingview.com
Published Jul 27, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 12:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
ARI Q2'26 Earnings: EPS estimate is 0.11 USD — source image
Source · tradingview.com
Decision brief

The 30-second read

$ARINeutralMed
01

Why it matters

Traders can use the provided consensus anchors ($34.70M revenue, $0.11 EPS) to frame expected beat/miss thresholds and manage event risk into the open.

02

Market read

Consensus EPS and revenue expectations are provided ahead of the print, which can influence near-term positioning and implied volatility.

03

What to watch

Earnings reaction may hinge more on credit performance, net interest margin, and guidance language than on the headline consensus revenue and EPS figures.

Relevance 5/10Novelty 5/10Timing: Ahead of ARI Q2'26 earnings release on July 28, expected 8:00 AM ET.

Background

The article is a pre-announcement preview for ARI’s Q2'26 earnings, scheduled for July 28 (8:00 AM ET).

Company-level read

Ticker impact

$ARINeutralMedium confidence
Context

ARI is scheduled to report Q2'26 results July 28, with consensus revenue of $34.70M and EPS of $0.11.

Expected impact

Moderate two-sided reaction risk around the July 28 open depending on whether reported EPS and revenue beat or miss the $0.11 and $34.70M expectations.

Evidence & confidence

The text is a pre-earnings preview with specific consensus numbers, but it does not include any new company-specific guidance or results.

Market effects

Sector

Limited read-across, since the article does not provide sector-wide data or rate/credit-cycle commentary.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

If ARI’s actual results diverge from consensus, the consensus preview may be less useful than any management commentary or credit-quality updates not included here.

Key entities

  • public_company
    ARI

    Apollo Commercial Real Estate Finance, Inc., scheduled to report Q2'26 results July 28.

Read at source← All news

Related articles

AUG 11
$ARIMed

Apollo Commercial Real Estate Finance, Inc. (ARI): Results of Operations and Financial Condition

Apollo Commercial Real Estate Finance, Inc. (ARI) filed an SEC Form 8-K — Results of Operations and Financial Condition. 8-K false 0001467760 0001467760 2026-08-10 2026-08-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10

SEC EDGAR 8-K3 min
JUN 15
$ARIMedAI 8/10

Apollo Commercial Real Estate Finance, Inc. Declares Quarterly Common Stock Dividend and Provides Update on Review of Strategic Alternatives

Apollo Commercial Real Estate Finance (NYSE:ARI) said its board declared a $3.75 per-share quarterly common stock dividend, payable July 15, 2026 to holders of record June 30, 2026, with most classified as return of capital. After reviewing strategic alternatives, the board determined dissolution and liquidation are advisable, subject to stockholder approval, and ARI plans to file a preliminary SEC proxy statement.

manilatimes.net4 min
AUG 13
$QTIMedAI 8/10

QT Imaging (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings (QTI) reported Q2 2026 revenue of $7.4 million, up 103% year over year, driven by 15 scanner shipments. First-half revenue was $14 million. Fiscal 2026 guidance calls for about $39 million revenue. Q2 gross margin was 41%; operating loss $1.9 million and net loss $11.1 million. Company extended debt to 2029 and raised $10 million via an offering.

fool.com7 min
AUG 13
$FENCMed

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals (NASDAQ:FENC) reported Q2 results on an earnings call. Net product sales were $17.1 million, up 78% year over year. Non-GAAP adjusted EBITDA was $2.8 million versus a $1.2 million loss a year earlier. Cash and cash equivalents were $41.2 million at June 30, 2026. Management cited PEDMARK momentum and no quantitative 2026 revenue outlook.

yahoo.com6 min
AUG 13
$MIDDMedAI 8/10

Middleby Q2 Earnings Call Highlights

Middleby (NASDAQ:MIDD) said dealer-channel growth remains positive but should moderate in H2, with Q3 and Q4 growth driven mainly by chain customers. Q2 organic adjusted EBITDA margin was 25.8%, below expectations due to mix, inflation and ice and beverage investments. Q2 adjusted EBITDA was ~$193M and adjusted EPS $2.35. Full-year organic growth outlook raised to 6% to 8%.

yahoo.com6 min
AUG 13
$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.

yahoo.com6 min